Tenofovir Alafenamide Tablets IP 25 MG – Tenorin AF 25 Tablets

Tenofovir Alafenamide Tablets IP 25 MG – Defense in Chronic Hepatitis B & HIV.

Tenorin AF 25 Tablets: The Composition of Tenofovir Alafenamide Fumarate 25 mg provides two antiviral therapy agents. TAF is a newer generation prodrug with improved intracellular delivery and reduced systemic exposure, leading to better safety. Both variants are essential components in treating chronic Hepatitis B and HIV-1 infection, either as monotherapy or in fixed-dose combinations.

Recommended By Specialists:
Infectious Disease Specialist: It is preferred to treat the disease associated with HIV management.
General Physicians: It is preferred to treat the disease associated with HIV/HBV management in specific setups.

Key Benefits of Tenofovir Alafenamide Tablets IP 25 MG – Tenorin AF 25 Tablets:
Potent Viral Suppression – Inhibits HBV DNA polymerase and HIV reverse transcriptase, reducing viral replication effectively.
Renal & Bone Safety (TAF)—*It offers similar efficacy to TDF but significantly lower impact on kidney and bone health.
Once-Daily Dosing – Convenient dosing regimen enhances compliance for long-term management in chronic infections.

INDICATIONS:
Chronic Hepatitis B Infection
HIV-1 Management (in combination regimens)
HBV Reactivation Prophylaxis
Renal-Safe Option (TAF preferred)
ART Regimen Backbone